A Phase I Study Evaluating the Safety and Persistence of Allorestricted WT1-TCR Gene Modified Autologous T Cells in Patients with High-Risk Myeloid Malignancies Unsuitable for Allogeneic Stem Cell Transplantation
暂无分享,去创建一个
A. Khwaja | E. Nicholson | N. Mount | W. Qasim | S. Xue | H. Zhan | E. Morris | H. Stauss | A. Holler | Mandana Ahmadi | R. Chakraverty | K. Gunter | S. Thomas | S. Robinson | J. Barry | P. Kottaridis | T. Fox | K. Thomson | Nourrédine Himoudi | R. Richardson | I. Martínez-Dávila | M. Sharpe | S. Inman | A. Virchis | J. King | Francesca Sillito | M. Quaye | Terri L. Gaskell | Rita Tendeiro-Rego